Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.

Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.

Item
http://www.wikidata.org/entity/Q30891180
Estimating the Risks and Benefits of Implantable Cardioverter Defibrillator Generator Replacement: A Systematic Review.Hospice Use Following Implantable Cardioverter-Defibrillator Implantation in Older Patients: Results From the National Cardiovascular Data Registry.Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator.Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts SymposiumCapsule Commentary on Al-Khatib et al., Future Research Prioritization: Implantable Cardioverter Defibrillator Therapy in Older Patients.Future Research Prioritization: Implantable Cardioverter-Defibrillator Therapy in Older PatientsEffect of Advancing Age and Multiple Chronic Conditions on Mortality in Patients with End-Stage Renal Disease after Implantable Cardioverter-Defibrillator Placement.Geographic and Temporal Variation in Cardiac Implanted Electric Devices to Treat Heart FailureProcedural outcomes and long-term survival following lead extraction in octogenarians.Influence of patients' age at implantation on mortality and defibrillator shocks.Let's talk chronic heart failure.New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials.Defibrillators work: now it is time to find out who needs them.Increasing age does not affect time to appropriate therapy in primary prevention ICD/CRT-D: a competing risks analysis.Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.Arrhythmias in Patients ≥80 Years of Age: Pathophysiology, Management, and Outcomes.Frailty as a Risk Factor for Cardiovascular Versus Noncardiovascular Mortality in Older Men: Results From the MrOS Sleep (Outcomes of Sleep Disorders in Older Men) Study.
P2860

Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.

Item
http://www.wikidata.org/entity/Q30891180
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Survival benefit of the primar ...... d data from 5 clinical trials.
@ast
Survival benefit of the primar ...... d data from 5 clinical trials.
@en
type
label
Survival benefit of the primar ...... d data from 5 clinical trials.
@ast
Survival benefit of the primar ...... d data from 5 clinical trials.
@en
prefLabel
Survival benefit of the primar ...... d data from 5 clinical trials.
@ast
Survival benefit of the primar ...... d data from 5 clinical trials.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Survival benefit of the primar ...... d data from 5 clinical trials.
@en
P2093
P2860
P304
P31
P356
10.1161/CIRCOUTCOMES.114.001306
P433
P478
P50
P577
P5875
P698
P921
P932